Does Arterialization of Portal Vein Have Any Effects in Large-for-Size Liver Transplantation? Hemodynamic, Histological, and Biomolecular Experimental Studies

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTORRES, Rafael Rodrigues
dc.contributor.authorTANNURI, Ana Cristina Aoun
dc.contributor.authorSERAFINI, Suellen
dc.contributor.authorBELON, Alessandro
dc.contributor.authorGONCALVES, Josiane Oliveira
dc.contributor.authorLORETO, Celso di
dc.contributor.authorTANNURI, Uenis
dc.date.accessioned2022-06-20T15:31:06Z
dc.date.available2022-06-20T15:31:06Z
dc.date.issued2022
dc.description.abstractBackground: In pediatric liver transplantation, the optimal size of the transplanted liver ranges between 0.8% and 4.0% of the recipient's weight. Sometimes, the graft weight exceeds this upper limit, characterizing the large-for-size condition potentially associated with reduced blood flow and worsening of ischemia-reperfusion injury. Therefore, it would be beneficial to increase the portal flow through arterialization of the portal vein. Materials and methods: Fifteen pigs underwent large-for-size liver transplants. They were divided into two groups: control (CTRL 6 animals - conventional technique) and arterialization - a shunt was established between the portal vein and the splenic artery (ART 9 animals). Hemodynamic, biochemical, histological, and molecular variables were compared. Results: Arterialization resulted in a significant increase in portal vein pressure but no changes in other hemodynamic variables, as shown in the analysis of variance. It was observed lower ALT values (p = 0.007), with no differences regarding the values of blood pH and lactate (p = 0.54 and p = 0.699 respectively) or histological variables (edema, steatosis, inflammation, necrosis, and IRI - p = 1.0, p = 0.943, p = 0.174, p = 0.832, p = 0.662, respectively). The molecular studies showed significantly increased expression of IL6 after 3 hours of reperfusion (p = 0.048) and decreased expression of ICAM immediately after reperfusion (p = 0.03). The regression analysis suggested a positive influence of portal flow and pressure on biochemical parameters. Conclusion: Arterialization of the portal vein showed no histological, biochemical, or molecular benefits in large-for-size transplantation.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/19098-9]
dc.identifier.citationJOURNAL OF INVESTIGATIVE SURGERY, v.35, n.6, p.1197-1207, 2022
dc.identifier.doi10.1080/08941939.2021.2021333
dc.identifier.eissn1521-0553
dc.identifier.issn0894-1939
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/47205
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS INCeng
dc.relation.ispartofJournal of Investigative Surgery
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright TAYLOR & FRANCIS INCeng
dc.subjectLarge-for-size liver transplantationeng
dc.subjectcomplications of liver transplantationeng
dc.subjectliver transplantationeng
dc.subjectpediatric liver transplantationeng
dc.subjectanimal modeleng
dc.subject.otherischemia-reperfusion injuryeng
dc.subject.othersalvage procedureeng
dc.subject.othermodeleng
dc.subject.otherhepatectomyeng
dc.subject.othermechanismseng
dc.subject.wosSurgeryeng
dc.titleDoes Arterialization of Portal Vein Have Any Effects in Large-for-Size Liver Transplantation? Hemodynamic, Histological, and Biomolecular Experimental Studieseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcRAFAEL RODRIGUES TORRES
hcfmusp.contributor.author-fmusphcANA CRISTINA AOUN TANNURI
hcfmusp.contributor.author-fmusphcSUELLEN SERAFINI
hcfmusp.contributor.author-fmusphcALESSANDRO RODRIGO BELON
hcfmusp.contributor.author-fmusphcJOSIANE DE OLIVEIRA GONCALVES
hcfmusp.contributor.author-fmusphcCELSO DI LORETO
hcfmusp.contributor.author-fmusphcUENIS TANNURI
hcfmusp.description.beginpage1197
hcfmusp.description.endpage1207
hcfmusp.description.issue6
hcfmusp.description.volume35
hcfmusp.origemWOS
hcfmusp.origem.pubmed34965813
hcfmusp.origem.scopus2-s2.0-85122076034
hcfmusp.origem.wosWOS:000736438100001
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceTannuri ACA, 2017, PEDIATR TRANSPLANT, V21, DOI 10.1111/petr.12928eng
hcfmusp.relation.referenceTannuri ACA, 2016, CLINICS, V71, P185, DOI 10.6061/clinics/2016(04)01eng
hcfmusp.relation.referenceBasso Celeste Del, 2021, Ann Hepatobiliary Pancreat Surg, V25, P426, DOI 10.14701/ahbps.2021.25.3.426eng
hcfmusp.relation.referenceBelon AR, 2022, J INVEST SURG, V35, P900, DOI 10.1080/08941939.2021.1933274eng
hcfmusp.relation.referenceBhangui P, 2014, HPB, V16, P723, DOI 10.1111/hpb.12200eng
hcfmusp.relation.referenceDatta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683eng
hcfmusp.relation.referencede Pinho-Apezzato ML, 2011, PEDIATR TRANSPLANT, V15, P617, DOI 10.1111/j.1399-3046.2011.01538.xeng
hcfmusp.relation.referenceFARHOOD A, 1995, J LEUKOCYTE BIOL, V57, P368, DOI 10.1002/jlb.57.3.368eng
hcfmusp.relation.referenceLeal AJG, 2015, CLINICS, V70, P126, DOI 10.6061/clinics/2015(02)10eng
hcfmusp.relation.referenceLeal AJG, 2013, CLINICS, V68, P1152, DOI 10.6061/clinics/2013(08)15eng
hcfmusp.relation.referenceGuan LY, 2014, WORLD J GASTRO SURG, V6, P122, DOI 10.4240/wjgs.v6.i7.122eng
hcfmusp.relation.referenceKasahara M, 2021, TRANSPLANTATION, V105, P2587, DOI 10.1097/TP.0000000000003610eng
hcfmusp.relation.referenceKlune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003eng
hcfmusp.relation.referenceKobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8eng
hcfmusp.relation.referenceMajlesara A, 2021, CAN J SURG, V64, pE173, DOI 10.1503/cjs.012419eng
hcfmusp.relation.referenceMatsushima H, 2020, TRANSPLANTATION, V104, P770, DOI 10.1097/TP.0000000000002968eng
hcfmusp.relation.referenceNardo B, 2006, TRANSPLANT P, V38, P1195, DOI 10.1016/j.transproceed.2006.04.002eng
hcfmusp.relation.referenceOgata A, 1997, J GASTROEN HEPATOL, V12, P633, DOI 10.1111/j.1440-1746.1997.tb00526.xeng
hcfmusp.relation.referencePulitano C, 2017, LIVER TRANSPLANT, V23, P527, DOI 10.1002/lt.24721eng
hcfmusp.relation.referenceMoreira DDAR, 2014, J SURG RES, V189, P313, DOI 10.1016/j.jss.2014.03.018eng
hcfmusp.relation.referenceShimizu Y, 2000, BRIT J SURG, V87, P784, DOI 10.1046/j.1365-2168.2000.01382.xeng
hcfmusp.relation.referenceTannuri U, 2008, PEDIATR TRANSPLANT, V12, P73, DOI 10.1111/j.1399-3046.2007.00801.xeng
hcfmusp.relation.referenceTannuri U, 2014, CLINICS, V69, P42, DOI 10.6061/clinics/2014(Sup01)08eng
hcfmusp.relation.referenceUhlmann D, 2000, J CARDIOVASC PHARM, V36, pS212, DOI 10.1097/00005344-200036001-00064eng
hcfmusp.relation.referenceZakaria HM, 2021, PEDIATR TRANSPLANT, V25, DOI 10.1111/petr.14044eng
hcfmusp.relation.referenceZhang K, 2014, WORLD J GASTROENTERO, V20, P12359, DOI 10.3748/wjg.v20.i34.12359eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationd2660c0f-2e12-4d4b-b66e-d421d696bba4
relation.isAuthorOfPublication6af04054-c85f-4b90-b417-af1c2dbab478
relation.isAuthorOfPublication44bbfe2e-509a-45f9-84af-652f129ae3dc
relation.isAuthorOfPublication65d01e9d-e9a6-489b-9ed6-3f50caff37d3
relation.isAuthorOfPublicationc99a7d1c-bd0d-472c-adf9-24e234620b5a
relation.isAuthorOfPublicationd0d1e796-c0f2-4ec0-a823-8b60d20b33ea
relation.isAuthorOfPublication1d894555-2ba1-4d5b-99e4-5cd8baab034a
relation.isAuthorOfPublication.latestForDiscoveryd2660c0f-2e12-4d4b-b66e-d421d696bba4
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_TORRES_Does_Arterialization_of_Portal_Vein_Have_Any_Effects_2022.PDF
Tamanho:
1.73 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)